Albatroz Data: Calnexin Inhibition May Reverse Arthritis
10 Apr 2025 //
GLOBENEWSWIRE
Singapore-based startup Albatroz secures $3 M to develop solid tumour therapy
04 May 2023 //
BIOSPECTRUM ASIA
Albatroz Secures $3 M to Develop First-Ever Therapy Blocking a
25 Apr 2023 //
BUSINESSWIRE

Market Place
Sourcing Support